SANOFI |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.86 EUR | +0.38% |
|
+0.77% | +0.11% |
| May. 27 | Sanofi Gets US FDA’s Priority Review for Expanded Use of Blood Cancer Drug Sarclisa | MT |
| May. 27 | Sanofi: FDA grants priority review in myeloma | CF |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- SAN Stock
- Revisions Sanofi
